Neo-adjuvant Immunotherapy Master Trial for Localized Cancers

Clinical trial NCT07262489 · RECRUITING

Trial details

NCT number: NCT07262489
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Localized Cancer

Start date: 2026-01-21
Primary completion: 2029-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.